Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer

Gynecologic and Obstetric Investigation

Volumn 44, Issue 1, 1997, Pages 57-60

  Kanamori, Yasunobu ^a   Kigawa, Junzo ^a   Minagawa, Yukihisa ^a   Irie, Takashi ^a   Ilamochi, Hiroaki ^a   Cheng, Xinsi ^a   Okada, Makoto ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Cisplatin; Intra arterial infusion

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PLATINUM;

ADULT; ADVANCED CANCER; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TUMOR LEVEL; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0030790310     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291411     Document Type: Article

References (11)

1. Kigavva J, Kanamori Y, ishihara H, Minagawa Y, Iwamoto K, Terakawa N: Response rate and cell cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent cervical cancer. Am J Clin Oncol 1992;15:474-479.
2. Panici PB, Greggi S, Scambia G, Ragusa G, Baiocchi G, Battaglia F. Coronetta F. Mancuso S: High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report. Gynecol Oncol 1991:41:212-216.
3. Sardi J, Sananes C, Giari A, Maya G, Paola G: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-489.
4. Scarabelli C, Tumolo S, De Paoli A, Frustaci C, Campagnutta E, Morassut S, Franchin G, Cri-vellari D, Sopracordevolc F, Lo Re G, Grigolet-to E, Monfardini S: Intermittent pelvic arterial infusion with peptichcmio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 1987; 60:25-30.
5. Collins JM: Pharmacokinetics rationale for intra-arterial therapy; in Kimura K, Ota K, Canter SK, Pinedo HK (eds): Cancer Chemotherapy Challenged for the Future. Amsterdam, Ex-cerpta Medica, 1988, pp 3-11.
6. Patton TJ, Kavanagh JJ, Delclos L, Wallace S, Haynie TP, Gershenson DM. Wharton JT, Bass S: Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous cell carcinoma of the cervix and vagina. Gynecol Oncol 1991;42: 54-59.
7. Hecquct B, Vennin P. Fournier C, Poissonnier B: Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diammincdichloroplati-num administration in patients with uterine cervical cancer. Cancer Res 1987;47:6134-6137.
8. Seldinger SI: Catheter replacement of the needle in percutaneous arteriography. Acta Radiol 1953;39:368-376.
9. LeRoy AF, Wehling ML, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, Litterst CL, Gram TE, Guarino AM, Becker DA: Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Bio-chemMed 1977;18:184-191.
10. Kigawa J, Minagawa Y, Itamochi H, Kanamori Y, Ishihara H, Terakawa N: Platinum concentrations in uterus and scrum after the internal iliac arterial infusion of platinum compounds in rabbits. Obstct Gynecol 1995;86:265-268.
11. Jafee N, Knapp J, Chuang VP. Wallace S, Ayala A, Murray J. Cangir A, Wang A. Benjamin RS: Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer 1983;51:402-407.